Health Care & Life Sciences » Biotechnology | Anthera Pharmaceuticals Inc.

Anthera Pharmaceuticals Inc. | Mutual Funds

Mutual Funds that own Anthera Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
FCP OP Medical BioHe@lth-Trends
96,500
0.37%
0
0%
11/30/2017
Pharma/wHealth Fund
17,500
0.07%
0
0%
11/30/2017
RIM Global - CC Bioscience
13,000
0.05%
13,000
0.01%
06/30/2017
Meeder Spectrum Fund
9,035
0.04%
1,913
0%
06/29/2018
4,187
0.02%
0
0%
09/05/2018
BlackRock Master Extended Market Index Series
690
0%
0
0%
01/31/2018
Vanguard Invt. Fds. ICVC - US Equity Index Fund
649
0%
0
0%
06/30/2018
Illinois State Board of Investment
475
0%
-613
0%
06/30/2016
APO Medical Opportunities
0
0%
-141,250
0%
03/31/2018
Nikko Asset Global Medical Strategy Mother Fund
0
0%
-536
0%
08/01/2016

About Anthera Pharmaceuticals

View Profile
Address
25801 Industrial Boulevard
Hayward California 94545
United States
Employees -
Website http://www.anthera.com
Updated 07/08/2019
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines to treat serious and life threatening diseases. It offers Sollpura and blisibimod to treat diseases such as exocrine pancreatic insufficiency and Immunoglobulin A nephropathy. The company was founded by Paul F.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.